Big pharma fears drugs in crosshairs of US-EU tarrif spat
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top-selling medicines made in Europe from Novo Nordisk's Wegovy for weight loss to Merck's cancer immunotherapy Keytruda.
Business
• 18 Mar
